Literature DB >> 27807356

Nonalcoholic steatohepatitis (NASH) drugs market.

Sorcha Cassidy1, Basharut A Syed1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27807356     DOI： 10.1038/nrd.2016.188

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  21 in total

1.  A long-acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis partly through an FGF21-adiponectin-IL17A pathway.

Authors:  Lichen Bao; Jun Yin; Wen Gao; Qun Wang; Wenbing Yao; Xiangdong Gao
Journal:  Br J Pharmacol       Date:  2018-07-03       Impact factor: 8.739

2.  Withaferin A Improves Nonalcoholic Steatohepatitis in Mice.

Authors:  Daxesh P Patel; Tingting Yan; Donghwan Kim; Henrique B Dias; Kristopher W Krausz; Shioko Kimura; Frank J Gonzalez
Journal:  J Pharmacol Exp Ther       Date:  2019-08-16       Impact factor: 4.030

3.  Novel substituted pyrazolone derivatives as AMP-activated protein kinase activators to inhibit lipid synthesis and reduce lipid accumulation in ob/ob mice.

Authors:  Mei Zhang; Zhi-Fu Xie; Run-Tao Zhang; Da-Kai Chen; Min Gu; Shi-Chao Cui; Yang-Ming Zhang; Xin-Wen Zhang; Yan-Yan Yu; Jia Li; Fa-Jun Nan; Jing-Ya Li
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

4.  Synthesis and Biological Evaluation of a Series of Bile Acid Derivatives as FXR Agonists for Treatment of NASH.

Authors:  Hualing Xiao; Peng Li; Xiaolin Li; Haiying He; Jianhua Wang; Fengxun Guo; Jiliang Zhang; Luxia Wei; Hongmei Zhang; Yueyuan Shi; Lijuan Hou; Liang Shen; Zhengxia Chen; Chunyan Du; Shouliang Fu; Pengtao Zhang; Fei Hao; Ping Wang; Deming Xu; Wei Liang; Xin Tian; Aiming Zhang; Xingdong Cheng; Ling Yang; Xiangjian Wang; Xiquan Zhang; Jian Li; Shuhui Chen
Journal:  ACS Med Chem Lett       Date:  2017-10-31       Impact factor: 4.345

5.  MicroRNA-199a-3p attenuates hepatic lipogenesis by targeting Sp1.

Authors:  Yang Cheng; Li Huang; Jian Ping; Tianyang Chen; Jianjie Chen
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

6.  Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis.

Authors:  Tian Lan; Tonghao Xu; Yanfang Fu; Shuo Jiang; Xiaolin Liang; Ze Yu; Linyu Pan; Xianglu Rong; Jiao Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

7.  Evaluating the Relationship Between Lean Liver Volume and Fat-Free Mass.

Authors:  Jaydeep Sinha; Stephen B Duffull; Bruce Green; Hesham S Al-Sallami
Journal:  Clin Pharmacokinet       Date:  2020-04       Impact factor: 6.447

8.  Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly.

Authors:  Jorge Simon; Maitane Nuñez-García; Pablo Fernández-Tussy; Lucía Barbier-Torres; David Fernández-Ramos; Beatriz Gómez-Santos; Xabier Buqué; Fernando Lopitz-Otsoa; Naroa Goikoetxea-Usandizaga; Marina Serrano-Macia; Rubén Rodriguez-Agudo; Maider Bizkarguenaga; Imanol Zubiete-Franco; Virginia Gutiérrez-de Juan; Diana Cabrera; Cristina Alonso; Paula Iruzubieta; Manuel Romero-Gomez; Sebastiaan van Liempd; Azucena Castro; Ruben Nogueiras; Marta Varela-Rey; Juan Manuel Falcón-Pérez; Erica Villa; Javier Crespo; Shelly C Lu; Jose M Mato; Patricia Aspichueta; Teresa C Delgado; María Luz Martínez-Chantar
Journal:  Cell Metab       Date:  2020-02-21       Impact factor: 27.287

9.  A microfluidic patterned model of non-alcoholic fatty liver disease: applications to disease progression and zonation.

Authors:  Beyza Bulutoglu; Camilo Rey-Bedón; Young Bok Abraham Kang; Safak Mert; Martin L Yarmush; O Berk Usta
Journal:  Lab Chip       Date:  2019-09-10       Impact factor: 6.799

10.  Role of Aramchol in steatohepatitis and fibrosis in mice.

Authors:  Marta Iruarrizaga-Lejarreta; Marta Varela-Rey; David Fernández-Ramos; Ibon Martínez-Arranz; Teresa C Delgado; Jorge Simon; Virginia Gutiérrez-de Juan; Laura delaCruz-Villar; Mikel Azkargorta; José L Lavin; Rebeca Mayo; Sebastiaan M Van Liempd; Igor Aurrekoetxea; Xabier Buqué; Donatella Delle Cave; Arantza Peña; Juan Rodríguez-Cuesta; Ana M Aransay; Felix Elortza; Juan M Falcón-Pérez; Patricia Aspichueta; Liat Hayardeny; Mazen Noureddin; Arun J Sanyal; Cristina Alonso; Juan Anguita; María Luz Martínez-Chantar; Shelly C Lu; José M Mato
Journal:  Hepatol Commun       Date:  2017-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.